Vigene Biosciences is a leader in viral vector based gene delivery for both life science research, gene therapy and cell therapy purposes. Headquartered in Rockville, Maryland, Vigene offers AAV, lentivirus and adenovirus based products and custom services. Both research grade and cGMP grade AAV, lentiviral and adenoviral vectors are available. The products include ready-to-ship genome wide human cDNA ORF on adenoviral vectors; AAV shRNA, ready-to-use genome wide human cDNA ORF on lentiviral vectors and pre-made control GFP viruses.